Cardiovascular and Metabolic Market Research and Competitive Intelligence Leaders
Because CVrg’s analysts are experts in the CVM therapy areas to which they are dedicated year-round, they are highly proficient in conducting CI surveillance, are adept at discerning what new scientific, clinical, regulatory, and market developments will impact their landscapes, and provide intelligent insight to clients about the future marketplace.
CVrg analysts vigilantly monitor multiple primary and secondary sources to comprehensively cover clinical trials, product developments, company activities, current treatment, and regulatory news to deliver monthly reports with unparalleled CI value.
CVrg Sentinel Includes:
CVrg tracks and provides insight into new trials as well as significant changes to completion dates, design, and enrollment targets.
|
![]() |
CVrg Sentinel Includes:
Data published in scientific and medical journals, press releases, trial databases, or other sources are evaluated with our analysis.
|
![]() |
CVrg Sentinel Includes:
We provide updates including regulatory submissions, advisory committees, approvals, and special designations in key regions.
|
![]() |
CVrg Sentinel Includes:
Our analysis includes pipeline updates, R&D collaborations, M&A news, major funding changes, and other commercial developments.
|
![]() |
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
About CVrg
Our Team
Careers
Contact
Home
CardioVascular
Acute Coronary Syndromes
Atrial Fibrillation & Stroke Prevention in AFib
Dyslipidemia/Atherosclerosis
Heart Failure
Peripheral Arterial Disease
Pulmonary Hypertension
Venous Thrombosis
Metabolic
Chronic Kidney Disease
Metabolic Dysfunction-Associated Steatohepatitis
Obesity
Type 1 Diabetes
Type 2 Diabetes
Conferences
ACC
EASL
ATS
HF-ESC
ERA
ADA
ESC
EASD
ERS
ASN
AASLD
AHA
ASH